News

  • 20 November 2011

    CorMatrix gets FDA approval to begin CorMatrix ECM trial

    The US Food and Drug Administration (FDA) has granted investigational device exemption approval to CorMatrix Cardiovascular for an ongoing, multicentre, prospective and randomised clinical trial of the CorMatrix ECM.

  • 20 November 2011

    Spiracur begins SNaP wound care system study

    Spiracur has initiated a study to evaluate its SNaP wound care system to treat lower extremity diabetic, venous and mixed etiology wounds at Cardiff University School of Medicine.

  • 17 November 2011

    Landauer acquires IZI Medical Products

    Landauer, a provider of personal and environmental radiation monitoring services, has acquired all outstanding equity interests of US-based IZI Medical Products for around $93m.

  • 17 November 2011

    DFine commences StabiliT vertebral augmentation system trial

    DFine, a developer of minimally invasive radiofrequency targeted therapies, has begun a prospective and randomised study to investigate the clinical effectiveness of minimally invasive augmentation procedures in the treatment of...

  • 16 November 2011

    MDxHealth prostate cancer assay shows efficacy

    MDxHealth's Prostate ConfirmMDx test has been found to help urologists to distinguish between true negative biopsies and occult prostate cancers undetected by biopsy and histopathological review.